Allogeneic adipose-derived stem cells not checked

Celltex Therapeutics Corporation

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Culture expanded mesenchymal stem cells isolated from a patient's own abdominal fat tissue”In the company’s words, NCT05017298 on ClinicalTrials.gov
Tested for
Corona Virus Infection, Covid19
Main trialPhase 2
“This is an interventional new drug clinical trial for a Phase 2 randomized, double-blind, and placebo control study using intravenous injection of allogeneic adipose stem cells (Celltex AdMSCs) for subjects with severe COVID-19.”In the company’s words, NCT05017298 on ClinicalTrials.gov
Other names
Celltex-AdMSCs

Other drugs for Corona Virus Infection

All 43 drugs for Corona Virus Infection

Coming up0

No dates coming up.

Changes1

Last 90 days

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Unknown 1 Nov 2024 Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Allogeneic adipose-derived stem cells

Following is part of Solo: you see every change to Allogeneic adipose-derived stem cells the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in